The company filed a lawsuit asking for a federal court’s permission to change when it gives lucrative drug discounts to ...

The agency has placed a partial hold on the phase 2a PORTOLA trial evaluating the selective immunoproteasome inhibitor ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

The dual-mechanism drug targets ULBP6, which is secreted by tumor cells and ... The company previously announced results from ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

It's an exciting time for Wave. This year we have executed ahead of plan, delivered three positive clinical data sets, ...

The Biden administration cut pandemic-era health benefits, and the Harris campaign failed to present any comprehensive health ...

In August, Trump said he wouldn't rule out taking away access to mifepristone, which was also mentioned by the policy ...

SACRAMENTO, Calif. -- California voters decided on 10 ballot measures including one that would turn some nonviolent crimes, ...

In 2025, an annual $2,000 out-of-pocket cap will keep costs low for Medicare enrollees on drugs covered by Part D plans. A ...

Seniors have until Dec. 7 to make a decision about their 2025 plans. Help is available to review premiums, deductibles and ...